Newsletter | March 20, 2024

03.20.24 -- Is AI Biased Toward "Exceptional Responders?"

SPONSOR

Gone are the days of paper, illegible handwriting, and data quality nightmares. eCOA and ePRO are revolutionizing the way clinical trials generate data. Register today for the next Clinical Leader Solutions Expo for a comprehensive understanding of the available options from leading suppliers. A can’t-miss opportunity to conveniently find the trial data capture solution that aligns perfectly with your study objectives!

DECENTRALIZED TRIALS

We Want To Know: Is AI Biased Toward ‘Exceptional Responders?’

Ram Mukunda of IGC Pharma asks Michael Lingzhi Li of Harvard about the risks of using AI to identify only on a small subset of patients who would then be enrolled in a clinical trial.

Setting Up An eCOA Trial In A DCT Context: What You Should Know

Think about these three aspects when choosing an electronic Clinical Outcome Assessments provider and preparing to set up an eCOA clinical trial.

7 Considerations For eCOA Technology Solutions

Choosing the right vendor, solution, and deployment model is critical for a clinical trial to be successful. As a sponsor, consider these seven best practices when selecting the best eCOA.

Clinical Trials Delivered At Your Door

By utilizing MRN's extensive experience, global network, and innovative approach, learn how they are helping to deliver efficient, cost-effective, and successful trials wherever the patients live.

TRIAL MANAGEMENT

Advancing Alzheimer's Treatment Means Using The Best Biomarker(s) — But Which?

As the Alzheimer's disease community grapples with the intricacies of biomarkers, trial outcomes, and the need for more precise diagnostic tools, the path forward requires a significant shift, redefining expectations and embracing a more comprehensive understanding of the disease.

Reconsidering The 3+3 Dose Escalation In Oncology Studies

Learn why incorporating alternative study designs to efficiently determine a safe and optimal RP2D is paramount for clinical research in 2024 and beyond.

Exploring Global Clinical Research Perspectives On RA Insights

See how the research into Rheumatoid Arthritis, which affects 17.6 million people worldwide, aims to improve treatment effectiveness and future interventions.

CHOOSE YOUR OWN ADVENTURE

You're receiving the Wednesday edition of the Clinical Leader newsletter, focusing on Decentralized Trials and Trial Management. To make changes to your newsletter selections, update your topic preferences.

  • Clinical Sites | Patient Centricity | Patient Recruitment (Monday)
  • Clinical Trial Technology (Tuesday)
  • Decentralized Trials | Trial Management (Wednesday)
  • Outsourcing Models | Regulatory & Compliance (Thursday)
  • Clinical Data Management & Analytics | Trial Monitoring (Friday)

Learn more about our personalized newsletters here.

Connect With Clinical Leader: